Context: Genetic aberrations,\u2028inactivation, and tumor-piloted\u2028characterized by myeloid derived suppressive cells (MDSCs) expansion and dendritic cells (DCs) inhibition, concur in worsening PDAC prognosis.\u2028Objective: To verify whether PDAC affects immune cells in a Smad4-dependent manner and whether tumor-derived exosomes (Ex) play a part.\u2028Methods: Two pancreatic cancer cell lines were used: BxPC3 (Smad4 Homozygous Deletion, HD) and Smad4-transfected BxPC3 (BxPC3-Smad4+). 1%FCS- Conditioned media (CM) were obtained from these cell lines. Peripheral blood mononuclear cells from 10 blood donors were cultured (4 days) in unfractioned control medium, BxPC3/CM and BxPC3- Smad4+/CM, and in Ex-enriched (pellet), or Ex-free (supe...
Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease with an overall 5-year survival rat...
Pancreatic ductal adenocarcinoma (PDAC) is characterized by rich deposits of extracellular matrix (E...
International audiencePancreatic ductal adenocarcinoma (PDAC) is a fatal disease with rising inciden...
Genetic aberrations, including Smad4 inactivation, and tumor-piloted immunoevasion, characterized by...
Genetic aberrations, including Smad4 inactivation, and tumor-piloted immunevasion, characterized by ...
Tumor genetics and escape from immune surveillance concur in the poor prognosis of PDAC. In this stu...
[[abstract]]BACKGROUND:SMAD4 is a gastrointestinal malignancy-specific tumor suppressor gene found m...
Objective: An altered function of lymphocytes, DC and immature myeloid cells appears to be an hallma...
The high progression rate of Pancreatic Ductal Adenocarcinoma (PDAC) depends on intrinsic genetic an...
BACKGROUND: Blood and spleen expansion of immature myeloid cells (IMCs) might compromise the immune ...
Background: Much evidence exists regarding the fact that blood DCs, both myeloid DCs (MDCs) and plas...
For many years, during clinical practices, pancreatic ductal adenocarcinoma (PDAC) has been regarded...
Context An altered function of lymphocytes, DC and immature myeloid cells appears to be an hallmark ...
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy characterized by extensive local...
Background: Pancreatic ductal adenocarcinoma (PDAC) is a highly devastating disease with an overall ...
Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease with an overall 5-year survival rat...
Pancreatic ductal adenocarcinoma (PDAC) is characterized by rich deposits of extracellular matrix (E...
International audiencePancreatic ductal adenocarcinoma (PDAC) is a fatal disease with rising inciden...
Genetic aberrations, including Smad4 inactivation, and tumor-piloted immunoevasion, characterized by...
Genetic aberrations, including Smad4 inactivation, and tumor-piloted immunevasion, characterized by ...
Tumor genetics and escape from immune surveillance concur in the poor prognosis of PDAC. In this stu...
[[abstract]]BACKGROUND:SMAD4 is a gastrointestinal malignancy-specific tumor suppressor gene found m...
Objective: An altered function of lymphocytes, DC and immature myeloid cells appears to be an hallma...
The high progression rate of Pancreatic Ductal Adenocarcinoma (PDAC) depends on intrinsic genetic an...
BACKGROUND: Blood and spleen expansion of immature myeloid cells (IMCs) might compromise the immune ...
Background: Much evidence exists regarding the fact that blood DCs, both myeloid DCs (MDCs) and plas...
For many years, during clinical practices, pancreatic ductal adenocarcinoma (PDAC) has been regarded...
Context An altered function of lymphocytes, DC and immature myeloid cells appears to be an hallmark ...
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy characterized by extensive local...
Background: Pancreatic ductal adenocarcinoma (PDAC) is a highly devastating disease with an overall ...
Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease with an overall 5-year survival rat...
Pancreatic ductal adenocarcinoma (PDAC) is characterized by rich deposits of extracellular matrix (E...
International audiencePancreatic ductal adenocarcinoma (PDAC) is a fatal disease with rising inciden...